951 related articles for article (PubMed ID: 16334761)
1. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
2. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
3. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
4. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
5. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.
Berberoglu U
Hepatogastroenterology; 2004; 51(60):1689-93. PubMed ID: 15532806
[TBL] [Abstract][Full Text] [Related]
7. Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists.
George S; Primrose J; Talbot R; Smith J; Mullee M; Bailey D; du Boulay C; Jordan H;
Br J Cancer; 2006 Oct; 95(7):841-7. PubMed ID: 16969342
[TBL] [Abstract][Full Text] [Related]
8. Variance of surgeons versus pathologists in staging of colorectal cancer.
Jha MK; Corbett WA; Wilson RG; Koreli A; Papagrigoriadis S
Minerva Chir; 2006 Oct; 61(5):385-91. PubMed ID: 17159746
[TBL] [Abstract][Full Text] [Related]
9. What factors affect lymph node yield in surgery for rectal cancer?
Thorn CC; Woodcock NP; Scott N; Verbeke C; Scott SB; Ambrose NS
Colorectal Dis; 2004 Sep; 6(5):356-61. PubMed ID: 15335370
[TBL] [Abstract][Full Text] [Related]
10. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
[TBL] [Abstract][Full Text] [Related]
11. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
Yano H; Saito Y; Kirihara Y; Takashima J
Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
[TBL] [Abstract][Full Text] [Related]
12. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
13. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
[TBL] [Abstract][Full Text] [Related]
14. Estimation of the number of metastatic lymph nodes in dukes' C colorectal cancer.
Fukushima T; Akagi Y; Murakami H; Ushijima M; Ogata Y; Shirouzu K; Murotani K
Anticancer Res; 2013 Jul; 33(7):2949-55. PubMed ID: 23780985
[TBL] [Abstract][Full Text] [Related]
15. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
16. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
[TBL] [Abstract][Full Text] [Related]
17. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
18. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
19. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between metastatic rate and amount of lymph nodes and prognosis of gastric cancer].
Li K; Xu HM; Chen JQ
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2113-6. PubMed ID: 16313820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]